Circulation, Vol 86, 1439-1442, Copyright © 1992 by American Heart Association
M Viitasalo and J Karjalainen
BACKGROUND. Conflicting reports about changes in QT intervals suggest that
QT values should be compared at similar heart rates. METHODS AND RESULTS.
Relations between QT and RR intervals were determined after measurement of
QT values by Holter recording at heart rates of 50, 60, 70, 80, 90, 100,
110, and 120 beats per minute in 100 healthy young men. Fifteen men
underwent a second recording during acute treatment with the beta-blocking
agent atenolol. At heart rates between 80 and 120 beats per minute, the QT
interval was significantly longer (from 9 to 16 msec), and at a heart rate
of 50 beats per minute significantly shorter (26 msec), than values
calculated from Bazett's formula. Sleep prolonged QT values by 18 msec at a
heart rate of 60 beats per minute and by 21 msec at a heart rate of 50
beats per minute compared with the waking state. Atenolol lengthened QT
intervals significantly (by 11-14 msec) at heart rates between 90 and 110
beats per minute and shortened them (by 12 msec) at a heart rate of 60
beats per minute. During sleep, QT intervals were the same before and after
atenolol. CONCLUSIONS. The method of plotting QT against RR intervals after
measurement of QT values at similar stable spontaneous heart rates before
and after intervention allows changes in autonomic state and heart rate to
be taken into account. By this method, QT values can be compared without
distortion effects caused by correction formulas.
ARTICLES
QT intervals at heart rates from 50 to 120 beats per minute during 24- hour electrocardiographic recordings in 100 healthy men. Effects of atenolol
First Department of Medicine, University Central Hospital, Helsinki, Finland.
This article has been cited by other articles:
![]() |
J.-P. Couderc, S. Kaab, M. Hinterseer, S. McNitt, X. Xia, A. Fossa, B. M. Beckmann, S. Polonsky, and W. Zareba Baseline Values and Sotalol-Induced Changes of Ventricular Repolarization Duration, Heterogeneity, and Instability in Patients With a History of Drug-Induced Torsades de Pointes J. Clin. Pharmacol., January 1, 2009; 49(1): 6 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Extramiana, F. Badilini, N. Sarapa, A. Leenhardt, and P. Maison-Blanche Contrasting Time- and Rate-Based Approaches for the Assessment of Drug-Induced QT Changes J. Clin. Pharmacol., September 1, 2007; 47(9): 1129 - 1137. [Abstract] [Full Text] [PDF] |
||||
![]() |
M Sugao, A Fujiki, M Sakabe, K Nishida, T Tsuneda, J Iwamoto, K Mizumaki, and H Inoue New quantitative methods for evaluation of dynamic changes in QT interval on 24 hour Holter ECG recordings: QT interval in idiopathic ventricular fibrillation and long QT syndrome Heart, February 1, 2006; 92(2): 201 - 207. [Abstract] [Full Text] [PDF] |
||||
![]() |
L Toivonen More light on QT interval measurement Heart, March 1, 2002; 87(3): 193 - 194. [Full Text] [PDF] |
||||
![]() |
A Plewan, G Lehmann, G Ndrepepa, J Schreieck, E.U Alt, A Schomig, and C Schmitt Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation. Sotalol vs bisoprolol Eur. Heart J., August 2, 2001; 22(16): 1504 - 1510. [Abstract] [PDF] |
||||
![]() |
A. Gastaldelli, M. Emdin, F. Conforti, S. Camastra, and E. Ferrannini Insulin prolongs the QTc interval in humans Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2000; 279(6): R2022 - R2025. [Abstract] [Full Text] [PDF] |
||||
![]() |
P Davey A new physiological method for heart rate correction of the QT interval Heart, August 1, 1999; 82(2): 183 - 186. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1992 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |